Loading

Please wait...

Emoquette

Generic Name: Ethinyl Estradiol and Desogestrel (ETH in il es tra DYE ole & des oh JES trel)
Brand Name: Apri, Azurette, Bekyree, Caziant, Cyclessa, ...show all 21 brand names.
Easy-to-read patient leaflet for Emoquette. Includes indications, proper use, special instructions, precautions, and possible side effects.
  • Prescription Settings

Prices and coupons of Emoquette

Current Location: 20149 (Ashburn)
Change Location?

Enter your zip code


Please wait while the prices are loaded...

Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:

Drug Information:
This is not a list of all drugs or health problems that interact with Emoquette (ethinyl estradiol and desogestrel). Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure that it is safe for you to take Emoquette (ethinyl estradiol and desogestrel) with all of your drugs and health problems. Do not start, stop, or change the dose of any drug without checking with your doctor. Use Emoquette (ethinyl estradiol and desogestrel) as ordered by your doctor. Read all information given to you. Follow all instructions closely. Learn more

Emoquette Side Effects

Emoquette Side Effects

Note: This document contains side effect information about desogestrel / ethinyl estradiol. Some of the dosage forms listed on this page may not apply to the brand name Emoquette.

For the Consumer

Applies to desogestrel / ethinyl estradiol: oral tablet

Warning

Oral route (Kit)

Smoking is not advised in women using oral contraceptives. Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. This risk increases with age and with heavy smoking (15 or more cigarettes per day) and is quite marked in women over 35 years of age.

Oral route (Tablet)

Ortho-Cept®: Cigarette smoking increases the risk of serious cardiovascular side effects from combination oral contraceptive use. This risk increases with age and with the number of cigarettes smoked and is quite marked in women over 35 years of age. Use of combination oral contraceptives is not recommended in women who are over 35 years of age that smoke. Velivet(TM): Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. This risk increases with age and with heavy smoking (15 or more cigarettes per day) and is quite marked in women over 35 years of age. Women who use oral contraceptives should be strongly advised not to smoke.Desogen®: Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive (COC) use. This risk increases with age, particularly in women over 35 years of age, and with the number of cigarettes smoked. For this reason, COCs are contraindicated in women who are over 35 years of age, and smoke.

Along with its needed effects, desogestrel / ethinyl estradiol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking desogestrel / ethinyl estradiol:

Incidence not known

  • Absent, missed, or irregular menstrual periods
  • anxiety
  • change in vision
  • changes in skin color
  • chest pain or discomfort
  • chills
  • clay-colored stools
  • constipation
  • cough
  • dark urine
  • diarrhea
  • dizziness, lightheadedness, fainting
  • fever
  • hives or welts
  • itching skin or rash
  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
  • nausea
  • pain or discomfort in the arms, jaw, back, or neck
  • pain, tenderness, or swelling of the foot or leg
  • pains in the chest, groin, or legs, especially in the calves of the legs
  • severe headaches of sudden onset
  • slow or fast heartbeat
  • stomach pain
  • sudden loss of coordination or slurred speech
  • sudden troubled breathing
  • sweating
  • unusual tiredness or weakness
  • vomiting
  • vomiting of blood

Some side effects of desogestrel / ethinyl estradiol may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Incidence not known

  • Bloating
  • blotchy spots on the exposed skin
  • breast enlargement or tenderness
  • feeling sad or empty
  • irritability
  • itching of the vagina or outside the genitals
  • loss of interest or pleasure
  • pain during sexual intercourse
  • thick, white curd-like vaginal discharge without odor or with mild odor
  • trouble wearing contact lenses

For Healthcare Professionals

Applies to desogestrel / ethinyl estradiol: oral tablet

Genitourinary

Common (1% to 10%): Breast pain/tenderness, amenorrhea, irregular bleeding

Uncommon (0.1% to 1%): Breast enlargement/hypertrophy, metrorrhagia

Rare (0.01% to 0.1%): Vaginal/breast discharge, vaginal candidiasis

Frequency not reported: Breakthrough bleeding, spotting, menstrual flow change, cervical ectropion and secretion, temporary infertility (after discontinuation), vaginitis, candidiasis, lactation diminution, premenstrual syndrome, dysmenorrhea, endometriosis, uterine myoma

Diminution of lactation may theoretically occur when this drug is given immediately postpartum.

Gastrointestinal

Common (1% to 10%): Nausea, abdominal pain

Uncommon (0.1% to 1%): Vomiting, diarrhea

Frequency not reported: Gallbladder disease, mesenteric thrombosis, gastrointestinal symptoms (e.g., abdominal pain, cramps, bloating), pancreatitis, colitis, Crohn's disease, ulcerative colitis

Psychiatric

Common (1% to 10%): Depressed mood, altered mood

Uncommon (0.1% to 1%): Decreased libido, nervousness

Rare (0.01% to 0.1%): Increased libido

Frequency not reported: Depression/mental depression

Nervous system

Common (1% to 10%): Headache, dizziness

Uncommon (0.1% to 1%): Migraine

Frequency not reported: Stroke, transient ischemic attack, cerebral hemorrhage/thrombosis, chorea exacerbation, Sydenham's chorea, epilepsy

Metabolic

Common (1% to 10%): Increased weight

Uncommon (0.1% to 1%): Fluid retention

Rare (0.01% to 0.1%): Decreased weight

Frequency not reported: Decreased serum folate, porphyria exacerbation, decreased carbohydrate tolerance, increased/decreased folate

Dermatologic

Uncommon (0.1% to 1%): Rash/allergic rash, urticaria, acne

Rare (0.01% to 0.1%): Erythema nodosum/multiforme, pruritus, alopecia, hirsutism

Frequency not reported: Scalp hair loss, melasma/chloasma or persistent melasma/chloasma, gestational herpes gestationis, hemorrhagic eruption

Cardiovascular

Uncommon (0.1% to 1%): Hypertension, fluid retention/edema

Rare (0.01% to 0.1%): Arterial/venous thromboembolism

Frequency not reported: Myocardial infarction, venous thrombosis, arterial/venous thromboembolic disorders, varicose vein aggravation, thrombophlebitis and venous thrombosis with/without embolism

Ocular

Rare (0.01% to 0.1%): Contact lens intolerance, cataract

Frequency not reported: Retinal thrombosis, optic neuritis, partial/complete vision loss, corneal curvature change/steepening

Hypersensitivity

Rare (0.01% to 0.1%): Hypersensitivity

Frequency not reported: Anaphylactic/anaphylactoid reactions, hereditary angioedema/angioedema, severe reactions with respiratory and circulatory symptoms

Other

Rare (0.01% to 0.1%): Otosclerosis

Hepatic

Frequency not reported: Cholestatic jaundice, Budd-Chiari syndrome, acute/chronic liver function disturbances, liver tumors/hepatic adenomas or benign liver tumors

Oncologic

Frequency not reported: Hormone-dependent tumors, breast cancer

Renal

Frequency not reported: Cystitis-like syndrome, impaired renal function

Respiratory

Frequency not reported: Pulmonary embolism

Hematologic

Frequency not reported: Hemolytic uremic syndrome

Musculoskeletal

Frequency not reported: Systemic lupus erythematosus

Editorial References and Review

Medically reviewed by BestRx Medical Team Last updated on 1/1/2020.

Source: Drugs.com Emoquette